http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
모니터링된 배터리 전압 변환을 위한 SAR typed A/D 컨버터의 제작
김성권,이경량,여성대,홍순양,박용운,Kim, Seong-Kweon,Lee, Kyung-Ryang,Yeo, Sung-Dae,Hong, Justin S.Y.,Park, Yong-Eun 한국전자통신학회 2011 한국전자통신학회 논문지 Vol.6 No.2
본 논문에서는 친환경 하이브리드 자동차의 핵심부품중 배터리 전압을 모니터하는 CVM(Cell Voltage Monitoring) 동작에서 모니터링된 배터리 전압을 디지털 데이터로 변환시키는 A/D (Analog to Digital) 컨버터의 설계 및 제작결과를 소개한다. CVM에 적정한 A/D컨버터는 중속동작 및 고분해능의 동작이 필요하여, SAR(Successive Approximate Register) typed A/D 컨버터 사용을 제안하였고, Magna 0.6um 40V 공정을 이용하여 10bits 분해능을 갖도록 설계 및 제작하였으며, 측정결과 FSR(Full Scale Range) 5V 전구간에서 ${\pm}1$ LSB Accuracy의 선형성을 확보하여, CVM 구현에 유용함을 나타내었다. In this paper, a design and an implementation of an Analog to Digital (A/D) converter are introduced for the conversion of monitored battery cell voltage in the cell voltage monitoring(CVM) system in battery management system(BMS), which is one of the key devices of ECO hybrid cars. The A/D converter in CVM system required a middle conversion speed and a high resolution, therefore, a successive approximate register(SAR) typed A/D converter with 10 bits resolution has been designed and implemented using Magna 0.6um 40V process. The measurement result which kept ${\pm}1$ LSB accuracy in the full scale range(FSR) of 5V, showed the usefulness of the SAR typed A/D converter in realizing a CVM system.
김연수(Y . S . Kim),이중건(J . G . Lee),정윤철(Y . C . Jung),이진학(J . H . Lee),최영진(Y . J . Choi),안규리(C . Ahn),한진석(J . S . Han),김성권(S . Kim),김병국(B . K . Kim),이정상(J . S . Lee),이현순(H . S . Lee) 대한내과학회 1994 대한내과학회지 Vol.46 No.2
Castlemam's disease is an asymptomatic and benign lymph node hyperplasia which is frequently manifested as mediastinal mass in over 70% of cases. Amyloidosis is rarely associated with Castleman's disease. Recently we experienced a patient with nephrotic syndrome due to renal amyloidosis who had been previously diagnosed as Castleman's disease of retroperitoneal lymph node enlargement. A 47-year old woman was admitted because of generalized edema and chest tightness. Five months ago she diagnosed as Castlman's disease-plasma cell type, of retroperitoneal lymph node enlargement. The patient was followed up through outpatient department without any specific medication. Physical examination showed pale conjunctivae, palpable mass on epigastric area and pretibial pitting edema. The hemoglobin, leukocyte count and erythrocyte sedimentation rate were 96 g/L, 5.9×109/L and 127 mm/hour, respectively. The blood urea nitogen was 3.6 mmol/L and creatinine was 88 umol/L. The urinalysis showed 3 positive for albumin. Twentyfour hour urine contained 16.6 grams of protein. A computerized tomographic (CT) scan of the abdomen disclosed multiple lymph node enlargement at mesentery. Percutaneous needle biopsy of kidney showed massive infiltration of pale pinkish amorphous material in the glomerular tuft forming large nodules. Ultrastructural examination exhibited heavy deposition of amyloid fibrils in the mesangium and perpendicular to glomerular basement membrane. Polarizing microscopy with Congo-red stain revealed prominent yellow green birefringence in glomeruli, tubules and interstitium.
신동맥분지협착에 의한 신혈관성고혈압 예에서 캅토프릴투여후 99mTc - DMSA 신 스캔
양원석(W . S . Yang),김연수(Y . S . Kim),엄재호(J . H . Earm),김상은(S . E . Kim),이동수(D . S . Lee),한진석(J . S . Han),정준기(J . K . Chung),김성권(S . K . Kim),이명철(M . C . Lee),이정상(J . S . Lee),고창순(C . S . Koh) 대한핵의학회 1990 핵의학 분자영상 Vol.24 No.2
N/A Radionuclide renal scintigraphies were performed in a 24-year-old man with right renal artery branch stenosis. Captopril enhanced Tc-99m-DTPA renal scintigraphy revealed no abnormal finding in the right kidney But, Tc-99m-DMSA renal scintigraphy showed regional cortical photon deficient area corresponding to the area supplied by the stenotic branch artery. The defect size increased in captopril enhanced Tc-99m-DMSA renal scintigrphy and nearly disappeared after successful transluminal renal angioplasty. This case suggests that the captopril enhanced Tc-99m- DMSA renal scintigraphy may be a useful method in the evaluation of renovascular hypertension, especially due to branch renal srtery stenosis.
김성권 ( S G Kim ),시차자 ( C J See ),김경애 ( K A Kim ),김의종 ( E J Kim ),석종성 ( J S Suk ) 대한임상검사과학회 1992 대한임상검사과학회지(KJCLS) Vol.24 No.1
Vitek system, a fully automated in vitro testing system designed for identification and antimicrobial susceptibility test of microorganisms was introduced to The Seoul National University Hospital in 1985. Principal advantages of using this system are rapid identification of microorganisms and rapid reporting of the minimal inhibitory concentration values. Using Vitek system, 248 isolates from culture requested blood specimen in our hospital from April 11. 1991 to August 31. 1991 were identified and minimal inhibitory concentration test were performed. We summarized the data and obtained results as below. 1. 52.3% of catalase +, Gram ( +) cocci, 75% of catalase(-), Gram(+) cocci, 74.8% of Gram (-) glucose fermenters and 57.1% of glucose nonf ermenters were identified within 9 hour. 2. Mic values of 87.6% of Gram ( +) cocci ( catalase +,- ) and 86.6% of Gram ( - ) rods (glucose fermenters and nonfermenters) were obtained within 9 hour. 3. 32.5% of isolated organisms were reported within the test performed day by using Vitek system.
김성균 ( Kim Seong Gyun ),김형직 ( Kim Hyeong Jig ),이정표 ( Lee Jeong Pyo ),이상구 ( Lee Sang Gu ),김연수 ( Kim Yeon Su ),안규리 ( An Gyu Li ),한진석 ( Han Jin Seog ),김성권 ( Kim Seong Gwon ),이정상 ( Lee Jeong Sang ),서경석 ( S 대한신장학회 2003 Kidney Research and Clinical Practice Vol.22 No.5
배 경 : 진행된 간질환의 치료로 간이식은 보편적으로 시행되고 있으며, 이식 후 생존율도 향상되어 간이식 후 장기 생존자가 증가하고 있다. 간이식 후 신기능 이상은 흔히 나타나며 예후에도 영향을 미치는 것으로 알려져 있으나 이에 대한 국내 연구는 미흡한 실정이다. 이에 저자들은 서울대학교병원에서 간이식 수술을 받고 6개월 이상 생존한 환자들을 대상으로 신기능 이상의 빈도와 위험인자에 대해 알아보았다. 방 법 : 1996년 11월부터 2001년 7월까지 간이식을 받은 만 15세 이상의 성인 환자 중 6개월 이상 생존한 62명을 대상으로 신기능의 변화를 알아보고 신기능 이상을 가져오는 위험인자를 알아보기 위해 본 연구를 후향적으로 수행하였다. 결 과 : 대상 환자는 남자가 44명 여자가 18명이었으며 나이는 45세 (증앙값, 16-64세)였다. 이들의 추적 관찰 기간은 17개월 (증앙값, 6-63개월)이었다. 간질환의 원인은 B형 간염 바이러스에 의한 간경변 43명, 간암 11명, C형 간염 바이러스에 의한 간경변 2명, 알콜성 간경변 2명, 윌슨병 1명 그리고 담도폐쇄증 1명이었다. 면역억제제는 tacrolimus (48명) 혹은 cyclosporine (14명)과 프레드니솔론 병합요법을 사용했으며, 26명의 환자들은 추적 기간 중에 신독성이 있는 칼시뉴린 억제제의 용량을 줄이면서 mycophenolate mofetil (MMF)를 투여 받았다. 간이식 후 6개월 후 사망한 환자는 1명이였으며 간암의 재발과 폐 전이에 의해 사망하였다. Cockcroft-Gault법을 이용한 크레아틴 청소율로 알아본 환자들의 신기능은 정상 신기능군 (Ccr>90) 8명 (13%), 경도의 신기능 이상군 (60<Ccr<90) 27명 (43.5%), 중등도의 신기능 이상군 (30<Ccr<60) 27명 (43.5%)이었으며 중증의 신기능 이상 (Ccr<30) 환자는 없었다. 중등도의 신기능 이상군과 그렇지 않은 군을 비교하였을 때 수술 전 크레아티닌 청소율 (p=0.007)과 3개월째 크레아티닌 청소율 (p=0.032)이 증등도 신기능 이상군에서 유의하게 낮았으며, 성, 나이, 면역억제제의 종류, 혈청 농도, 양, 수술 직후의 발생한 급성신부전, 수술 후 6개월간의 급성신부전의 횟수는 차이가 없었다. 신독성이 있는 칼시뉴린 억제제의 용량을 줄이면서 MMF를 투여 받은 환자들은 그렇지 않은 환자에 비해 통계학적으로 유의하지는 않으나 (p=0.057), 신기능이 회복되는 경향을 보였다. 결 론 : 간이식 수술을 받고 6개월이 지난 환자에서 신기능 이상은 87%로 매우 흔하며 중등도 이상의 신기능 이상도 43%에서 나타났다. 그리고 중등도 이상의 신기능 이상의 위험인자로 늘 수술 전 신기능 이상과 수술 후 3개월째 신기능 이상이 중요한 것으로 나타났다. 또 칼시뉴린 억제제의 신기능 이상을 줄이기 위한 MMF 투여에 대한 대규모 전향적인 연구가 필요할 것으로 생각된다. Background : Patients survival after liver transplantation continue to improve, and renal dysfunction is not uncommon complication in the posttransplant setting and influences to prognosis. But this important complication has not been extensively evaluated in Korea. The aim of this study was to determine the incidence of renal insufficiency and to identify the risk factors associated with renal insufficiency in long-term survivor over 6 months after liver transplantation at Seoul National University Hospital. Methods: A retrospective study was done of 62 adult (44 males, 18 females; mean age 45 years, range 16-64) patients surviving more than 6 months (mean 17 months, range 6-63) after liver transplantation in the period of November 1996 to July 2001. Renal function of patients was classified by estimated endogenous creatinine clearance using Cock-croft-Gault formula. Potential risk factors for renal insufficiency were investigated. In addition, in the cases of patient who received mycophenolate mofetil (MMF) with calcineurin inhibitors (CNI) in reduced dosages for presumed CNI-induced nephrotoxicity, the change of renal function was analyzed retrospectively. Results : The underlying diseases leading to transplantation included HBV-related cirrhosis in 43, hepatoma in 11, HCV-related cirrhosis in 2, alcoholic cirrhosis in 2, Wilson`s disease in 1, and biliary atresia in 1 case (s). The immunosuppressive therapy included tacrolimus in 48 cases and cyclosporine in 14 cases combined with prednisolone. In all, 26 patients among study period, received MMF. Of all patients, 8 (13%) kept normal renal function (Ccr≥90), 27 (43.5%) developed mild dysfunction (60≤Ccr<90), 27 (43.5%) developed moderate dysfunction (30≤Ccr<60), and none of these patients developed severe renal dysfunction (Ccr<30). Compared with control patients (Ccr>60), renal dysfunction patients (Ccr<60) had a lower preoperative creatinine clearance (p=0.007) and a lower 3-month creatinine clear ance (p=0.032). But there were no differences seen among groups in age, sex, immunosuppresive protocol (tacrolimus vs. cyclosporine), mean tacrolimus serum level, developement of postoperative acute renal failure (ARF), and frequency of ARF among 6 months after transplantation. There was no statistically significant (p=0.057) but some recovery of renal function in the cases of patient who received MMF with low dose CNI. Conclusion: Patients who are more than 6 months after liver transplantation have renal dysfunction at a high rate (87%). Patients who develop moderate renal dysfunction have a lower preoperative and 3-month creatinine clearance. For renoprotective effect of MMF with reduced dosageof CNI, long-term randomized controlled studies are warranted.